Cases

Defendants allegedly misrepresented that Anktiva would allow all NMIBC patients treated with Anktiva to be cancer-free for the long term, falsely characterised Anktiva as a cancer vaccine, and the Executive Chairman is alleged to have materially overstated Anktiva’s capabilities. The FDA warning letter dated 2026-03-13 found promotional materials misbranded Anktiva.

Allegedly false statements regarding Pinterest’s business resilience: failure to disclose that Pinterest faced reduced revenues from advertising partners, that the company overstated its ability to manage the impact of US tariffs on advertisers, and that Pinterest was facing or likely to face an imminent restructuring.

Allegedly false statements concerning Model 22, Upstart’s AI lending model. Defendants are alleged to have concealed that Model 22 frequently overreacted to negative macroeconomic signals; that the model’s accuracy and ability to increase loan approvals was overstated; and that Model 22’s overly conservative assessment negatively impacted revenue, making prior guidance unreliable.

Multiple professional-obligation breaches found by the AMF Enforcement Committee: misrepresentation of authorisation (Kerdiz falsely presented itself as an authorised investment-services provider and claimed AMF authorisation for Vivat Multitalent securities marketing); inadequate identification and management of conflicts of interest with the Vivat Multitalent group; failure to apply required product-governance procedures; advising clients on Multitalent AG / Multitalent II AG / Multitalent III AG / Multitalent Investment GmbH securities without verifying asset-management-company and depositary appointments and marketing prohibited securities in France; unauthorised direct-marketing campaign for the Guyane Agricole offer; and failure to exercise due diligence toward AMF inspectors. · Failure to comply with several anti-money-laundering and counter-terrorism-financing obligations.

Alleged false and/or misleading statements throughout the class period concerning Super Micro's exposure to U.S. export-control law: (i) a significant portion of server sales were to companies based in China; (ii) those transactions violated U.S. export control laws; (iii) there were material weaknesses in Super Micro's controls to ensure compliance with applicable export control laws and regulations.

ASIC alleged that senior management and the entire Star Board engaged in breaches of the duty of care and diligence under s 180(1) of the Corporations Act 2001 (Cth) by failing to give sufficient focus to the risk of money laundering and criminal infiltration inherent in operating a major casino, including with respect to Suncity relationships.

The Enterprise Chamber found valid reasons to doubt proper management at Nexperia under its previous governance structure and in light of certain actions taken by Wingtech since October 2025: a conflict of interest had been handled without due care; the former CEO is alleged to have changed Nexperia’s strategy without internal consultation under the threat of upcoming sanctions; agreements with the Netherlands Ministry of Economic Affairs were no longer adhered to; the powers of European managers were restricted and their dismissal had been announced.

Professional-obligation breaches identified by the AMF Enforcement Committee. Specific grounds not yet parsed from this release; verify against source.

Securities class-action allegations against Airbus and its former directors and supervisory directors. The cited sources describe the action as a securities class action under WAMCA but do not enumerate the specific allegations.

WAMCA opt-out securities action seeking compensation for investors who bought or held Fiat shares between October 2014 and May 2017 on the Milan exchange. Substantive merits not reviewed; the foundation was declared inadmissible.